Tumours are complex mixture of a heterogeneous population of cells that possess distinct genetic, morphological, and phenotypic profiles, which can affect tumour development and therapeutic resistance. The success of cancer…Read more
Dr. Van Maldegem from VUmc is one of the pioneers in using and developing Imaging Mass Cytometry (IMC) method for cancer research. IMC enables detailed and contextual characterisation of protein expression…Read more
The staff from the NIB Project Office, the Technology Transfer Office, the Public Relations Office, the Accountancy Department and the Human Resource Office attended the four-day training to gain new…Read more
Lecture within subject “Biochemistry of cancer initiation and progression”, Faculty of Pharmacy, University of LjubljanaRead more
Discover More About the Project
The overarching aim of CutCancer is to improve the scientific excellence and innovation capacity in the field of 3D in vitro cancer research at the National Institute of Biology, Slovenia.